Donor Bone Marrow Transplant in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Giving chemotherapy and total-body irradiation before a donor bone marrow
transplant helps stop the growth of cancer cells. It also helps stop the patient's immune
system from rejecting the donor's stem cells. When the stem cells from a related or unrelated
donor, that closely matches the patient's blood, are infused into the patient they may help
the patient's bone marrow to make stem cells, red blood cells, white blood cells, and
platelets.
PURPOSE: This phase II trial is studying how well donor bone marrow transplant works in
treating patients with leukemia, lymphoma, or nonmalignant hematologic disorders.
Phase:
Phase 2
Details
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute